Antonio Martinez-Perez - Publications

The use of mesenchymal stromal cells in steroid-refractory graft-versus-host disease after pediatric hematopoietic stem cell transplantation: a report of the Spanish group of stem cell transplantation (Geth).

Journal: Bone marrow transplantation

Published: April 21, 2025

Tabelecleucel in Post-transplant Epstein-Barr Virus-Associated Lymphoproliferative Disease: Patient and Oncologist Perspectives.

Journal: Advances in therapy

Published: January 29, 2025

Siltuximab for the treatment of early complications after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia in children, adolescents, and young adults.

Journal: Experimental hematology & oncology

Published: December 18, 2024

Therapeutic strategies and clinical evolution of patients with infantile fibrosarcoma: a unique paediatric case series.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: February 16, 2023

The need for evolution in the management of febrile neutropenia in pediatric cancer: TRIIO KIDS update.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: June 25, 2022

A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol.

Journal: Trials

Published: May 31, 2021

Experience of the Spanish Group for Hematopoietic Transplantation (GETMON-GETH) in allogenic Hematopoietic stem cell Transplantation in Philadelphia acute lymphoblastic leukemia.

Journal: Anales de pediatria

Published: November 05, 2020

Genetic predisposition to fetal and neonatal cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: July 07, 2020

Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemia.

Journal: BMJ open

Published: January 11, 2020

Immunotherapy with CAR-T cells in paediatric haematology-oncology

Journal: Anales de pediatria

Published: November 18, 2019

Possible role of highly activated mucosal NK cells against viral respiratory infections in children undergoing haematopoietic stem cell transplantation.

Journal: Scientific reports

Published: April 04, 2019

Memory T Cells Expressing an NKG2D-CAR Efficiently Target Osteosarcoma Cells.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 12, 2017